Back to Archived Journals » Oncolytic Virotherapy » Volume 5
Oncolytic Virotherapy ceased publishing in January 2023. All articles that have been published in Oncolytic Virotherapy will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Oncolytic Virotherapy
ISSN: 2253-1572
- View all (70)
- Volume 10, 2021 (1)
- Volume 9, 2020 (2)
- Volume 8, 2019 (6)
- Volume 7, 2018 (11)
- Volume 6, 2017 (6)
- Volume 5, 2016 (10)
- Volume 4, 2015 (20)
- Volume 3, 2014 (8)
- Volume 2, 2013 (5)
- Volume 1, 2012 (1)
Archive: Volume 5, 2016
CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter
Bhatia S, O’Bryan SM, Rivera AA, Curiel DT, Mathis JM
Oncolytic Virotherapy 2016, 5:99-113
Published Date: 11 November 2016
Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodes
Orloff M
Oncolytic Virotherapy 2016, 5:91-98
Published Date: 4 October 2016
Oncolytic Seneca Valley Virus: past perspectives and future directions
Burke MJ
Oncolytic Virotherapy 2016, 5:81-89
Published Date: 6 September 2016
Oncolytic virotherapy for pediatric malignancies: future prospects
Waters AM, Friedman GK, Ring EK, Beierle EA
Oncolytic Virotherapy 2016, 5:73-80
Published Date: 11 August 2016
Myxoma virus therapy of human embryonal rhabdomyosarcoma in a nude mouse model
Kinn VG, Hilgenberg VA, MacNeill AL
Oncolytic Virotherapy 2016, 5:59-71
Published Date: 8 August 2016
Oncolytic adenovirus-mediated therapy for prostate cancer
Sweeney K, Halldén G
Oncolytic Virotherapy 2016, 5:45-57
Published Date: 14 July 2016
Thyroid malignant neoplasm-associated biomarkers as targets for oncolytic virotherapy
Guan M, Ma Y, Shah SR, Romano G
Oncolytic Virotherapy 2016, 5:35-43
Published Date: 21 June 2016
Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy
Al-Shammari AM, Rameez H, Al-Taee MF
Oncolytic Virotherapy 2016, 5:27-34
Published Date: 20 April 2016
High-throughput screening to enhance oncolytic virus immunotherapy
Allan KJ, Stojdl DF, Swift SL
Oncolytic Virotherapy 2016, 5:15-25
Published Date: 5 April 2016
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
Simpson GR, Relph K, Harrington K, Melcher A, Pandha H
Oncolytic Virotherapy 2016, 5:1-13
Published Date: 6 January 2016